Worried about rising inflation? With nearly risk free I bonds soon to pay 9.62%, here’s what you need to know

Worried about rising inflation? With nearly risk free I bonds soon to pay 9.62%, here’s what you need to know


Eakgrunge | Istock | Getty Images

Less risk often means lower returns. But that’s not the case with I bonds, an inflation-protected and government-backed asset, which may soon pay an estimated 9.62%.

I bonds currently offer 7.12% annual returns through April, and the rate may reach 9.62% in May based on the latest consumer price index data. Annual inflation grew by 8.5% in March, according to the U.S. Department of Labor.

“The 9.62% is an eye-watering number,” said certified financial planner Christopher Flis, founder of Resilient Asset Management in Memphis, Tennessee. “Especially given how other fixed-income assets have performed this year.”

More from Your Money Your Future:

Here’s a look at more stories on how to manage, grow and protect your money for the years ahead.

Of course, the 9.62% return is an estimate until the U.S. Department of the Treasury announces new rates on May 2. Still, I bonds may be worth a look if you’re seeking ways to beat inflation. Here’s what to know before buying. 

How I bonds work

I bonds, backed by the U.S. government, won’t lose value and pay interest based on two parts, a fixed rate and a variable rate, changing every six months based on the consumer price index.

If you purchase I bonds by the end of April, you’ll lock in 7.12% for the next six months, followed by an estimated 9.62% for another six months, for a 12-month average of 8.37%, according to Ken Tumin, founder and editor of DepositAccounts.com, who tracks these assets. 

However, there are only two ways to purchase these assets: online through TreasuryDirect, limited to $10,000 per calendar year for individuals or using your federal tax refund to buy an extra $5,000 in paper I bonds. There are redemption details for each one here.

You may also buy more I bonds through businesses, trusts or estates. For example, a married couple with separate businesses may each purchase $10,000 per company, plus $10,000 each as individuals, totaling $40,000.

Downsides of I bonds

One of the drawbacks of I bonds is you can’t redeem them for at least one year, said George Gagliardi, a CFP and founder of Coromandel Wealth Management in Lexington, Massachusetts. And if you cash them in within five years, you’ll lose the previous three months of interest. 

“I think it’s decent, but just like anything else, nothing is free,” he said. 

Another possible downside is lower future returns. The variable portion of I bond rates may adjust downward every six months, and you may prefer higher-paying assets elsewhere, Gagliardi said. But there’s only a one-year commitment with a three-month interest penalty if you decide to cash out early.

Still, I bonds may be worth considering for assets beyond your emergency fund, Flis from Resilient Asset Management said.

“I think that the I bond is a wonderful place for people to put the money they don’t need right now,” he said, such as an alternative to a one-year certificate of deposit.

“But I bonds aren’t a replacement for long-term funds,” Flis said.



Source

Big Food gets leaner with divestitures and breakups as consumers turn away from packaged snacks
Business

Big Food gets leaner with divestitures and breakups as consumers turn away from packaged snacks

Kraft Heinz announced plans to split into two separately traded companies, reversing its 2015 megamerger, which was orchestrated by billionaire investor Warren Buffett. Justin Sullivan | Getty Images News | Getty Images Big Food is slimming down. As both consumers and regulators push back against ultra-processed foods, the companies that make them have been splitting […]

Read More
Eli Lilly CEO says Medicare coverage of obesity drugs could ‘change the game’ for upcoming pill launch
Business

Eli Lilly CEO says Medicare coverage of obesity drugs could ‘change the game’ for upcoming pill launch

Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major catalyst for the rollout of the company’s closely watched experimental weight loss pill, orforglipron. In an exclusive interview with CNBC, Ricks said Lilly expects to have Medicare coverage for the treatment “immediately following that launch, and that […]

Read More
GameStop’s Ryan Cohen eyes ‘very big’ consumer megadeal that could increase company’s value tenfold
Business

GameStop’s Ryan Cohen eyes ‘very big’ consumer megadeal that could increase company’s value tenfold

GameStop wants to acquire a publicly traded consumer company that’s far larger than the video game retailer in a deal that could be “transformational” for the company, CEO Ryan Cohen told CNBC in an interview Friday. “It’s gonna be really big. Really big. Very, very, very big,” Cohen said of the size of the acquisition. […]

Read More